Endocrine Society Clinical Practice Guideline examines better ways to manage hypoglycemia in people with diabetes.
A concise overview of the diagnosis, management, and outcomes of diabetic retinopathy .
Tzield is anti-CD3 monoclonal antibody that has been shown to preserve beta cell function, reducing the need for exogenous insulin.
Incidence lower in White patients vs Black, Hispanic, and indigenous populations.
Variation seen among subgroups, with rationing in 11.2% of those aged 65 years and older and 20.4% of younger persons.
Researchers evaluate the lifetime cost-effectiveness of using SGLT2 inhibitors or GLP1 receptor agonists as first-line treatments for type 2 diabetes.
Investigators conducted a meta-analysis of randomized controlled trials on the effect of SGLT-2 inhibitors on patients with HFpEF.
Unlike people with obesity, lean individuals may not experience health benefits with intentional weight loss.
Researchers compare the reduction in glycated hemoglobin level with use of a bionic pancreas compared with standard care in children and adults with type 1 diabetes.
Equipment issue may allow someone to break in and cause the pump to deliver too much or too little insulin to the patient.
A committee of nephrologists and cardiologists developed 6 recommendations to improve hyperkalemia management.
Maternal obesity with excessive weight gain linked to increased risk for ADHD in offspring vs normal weight without excessive weight gain.
Evidence insufficient for assessing benefits and harms of screening for children and adolescents.
Dr Ferrara discusses how to lobby for full practice authority and provides updates on federal legislation for NPs.
This study builds on recent research indicating that prescribing NPH insulin may be reasonable for older patients with concerns about medication costs, particularly when it is used in combination with prandial insulin.
Using definition based on both fasting plasma glucose and HbA1c, analysis shows proportion of undiagnosed diabetes cases down in US adults.
Daily insulin dose linked to cancer risk in multivariable model, with increasing cancer incidence in low-, medium-, high-dose insulin groups.
Limiting added sugar and refined grains helpful, but no added overall health benefit seen for cutting out legumes, fruits, and whole grains.
First Relief is a wearable PENS device that is placed behind the ear.
As part of California’s new budget, $50 million will go directly to the development of low-cost insulin products to increase access for patients with diabetes.